Skip to search formSkip to main contentSkip to account menu

Oxerutins

Known as: oxerutin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Objectives Chronic venous insufficiency (CVI) is an important cause of discomfort and inability to work. Hydroxyethylrutosides… 
Highly Cited
2006
Highly Cited
2006
The aim of this independent study was to investigate differences in efficacy between oxerutins (Venoruton) and 500 mg micronized… 
2005
2005
Accumulation of Advanced Lipoxidation End‐products (ALE), such as MDA‐ and HNE‐protein adducts, and Advanced Glycation End… 
Review
2004
Review
2004
BACKGROUND Lymphoedema is the accumulation of excess fluid in the body caused by obstruction of the lymphatic drainage mechanisms… 
Highly Cited
2003
Highly Cited
2003
This study analyzes the effect of chronic treatment with different antioxidants (N-acetyl-cysteine [NAC], taurine, a combination… 
Highly Cited
2002
Highly Cited
2002
The aim of this study was to confirm the clinical efficacy of oxerutins by evaluation of venous parietal tone and microvascular… 
1996
1996
The aim of this study was to investigate, if the the combined treatment of compression stockings and drug treatment with… 
1993
1993
Oxerutins (Venoruton) and troxerutin (CAS 7085-55-4) are both mixtures of O-(beta-hydroxyethyl)-rutosides used for the treatment… 
Highly Cited
1991
Highly Cited
1991
The value of oxerutins [O‐(β‐hydroxyethyl)‐rutosides] in the prevention of venous ulcer recurrence was investigated in a double…